Avalo Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Doyle Mittie | Chief Medical Officer | Tax Withholding | 1,013 | $4.10 | $4,153 | 3,622 | Dec 10, 2025 |
| Riley Jennifer | Chief Strategy Officer | Tax Withholding | 637 | $4.10 | $2,612 | 2,655 | Dec 10, 2025 |
| VARKI PAUL | Chief Legal Officer | Tax Withholding | 1,016 | $4.10 | $4,166 | 3,634 | Dec 10, 2025 |
| Sullivan Christopher Ryan | Chief Financial Officer | Tax Withholding | 155 | $4.10 | $636 | 17,338 | Dec 10, 2025 |
| Goldman Jonathan | — | Sale | 3,167 | $14.30 | $45,288 | — | Nov 14, 2025 |
| Chan Mitchell | — | Option Exercise | 3,167 | — | — | 3,167 | Mar 28, 2025 |
| Goldman Jonathan | — | Option Exercise | 3,167 | — | — | 3,167 | Mar 28, 2025 |
| Truex Samantha | — | Option Exercise | 3,167 | — | — | 3,167 | Mar 28, 2025 |
| KANTOFF AARON | — | Option Exercise | 3,167 | — | — | 3,167 | Mar 28, 2025 |
| KAPLAN GILLA | — | Option Exercise | 3,167 | — | — | 3,167 | Mar 28, 2025 |
| Almenoff June Sherie | — | Option Exercise | 3,167 | — | — | 3,167 | Mar 28, 2025 |
| Sullivan Christopher Ryan | Chief Financial Officer | Option Exercise | 24,200 | — | — | 24,206 | Mar 28, 2025 |
| NEIL GARRY ARTHUR | Chief Executive Officer | Option Exercise | 64,867 | — | — | 64,927 | Mar 28, 2025 |
| Almenoff June Sherie | — | Purchase | 500 | $13.00 | $6,500 | 1,000 | Nov 12, 2024 |
| Armistice Capital Master Fund Ltd. | — | Sale | 2,746,138 | $0.61 | $1,675,144 | 1,668,862 | Jun 27, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 182,300 | $0.62 | $113,026 | — | Jun 26, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 2,000 | $4.14 | $8,280 | 1,425,700 | Jun 15, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 8,750 | $3.82 | $33,425 | 1,411,540 | Jun 14, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 6,398 | $3.93 | $25,144 | 1,395,597 | Jun 9, 2023 |
| Sullivan Christopher Ryan | Chief Financial Officer | Purchase | 511 | $3.42 | $1,748 | 1,262 | Jun 9, 2023 |
| NEIL GARRY ARTHUR | CEO and Chairman of the Board | Purchase | 4,000 | $3.42 | $13,680 | 13,220 | Jun 9, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 844 | $2.87 | $2,422 | 1,386,215 | May 31, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 671 | $2.87 | $1,926 | 1,385,371 | May 25, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 5,519 | $2.96 | $16,336 | 1,382,700 | May 24, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 7,000 | $3.34 | $23,380 | 1,373,700 | May 19, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 1,715 | $2.55 | $4,373 | 1,346,700 | May 12, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 5,000 | $2.88 | $14,400 | 1,337,700 | May 4, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 5,571 | $3.00 | $16,713 | 1,315,771 | Apr 27, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 12,500 | $3.06 | $38,250 | 1,310,200 | Apr 20, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 10,000 | $2.94 | $29,400 | 1,292,700 | Apr 17, 2023 |
| Caissa Capital Management ltd. | — | Purchase | 31,329 | $2.28 | $71,430 | 1,242,700 | Apr 11, 2023 |
| ARMISTICE CAPITAL, LLC | — | Purchase | 450,000 | — | — | 4,415,000 | Feb 3, 2023 |
| NEIL GARRY ARTHUR | CEO and Chairman of the Board | Purchase | 2,083 | $4.42 | $9,207 | 9,220 | Dec 9, 2022 |
| ARMISTICE CAPITAL, LLC | — | Purchase | 100,000 | $0.65 | $65,000 | 47,576,000 | Mar 10, 2022 |
| Boyd Steven | — | Purchase | 50,000 | $0.71 | $35,500 | 46,890,000 | Mar 4, 2022 |
| Armistice Capital Master Fund Ltd. | — | Purchase | 40,000 | $0.79 | $31,600 | 46,840,000 | Feb 24, 2022 |
| Boyd Steven | — | Purchase | 55,000 | $0.82 | $45,100 | 46,617,000 | Feb 17, 2022 |
| ARMISTICE CAPITAL, LLC | — | Purchase | 93,700 | $0.88 | $82,456 | 46,400,000 | Jan 18, 2022 |
| Boyd Steven | — | Purchase | 85,000 | $0.93 | $79,050 | 46,100,000 | Jan 13, 2022 |
| Armistice Capital Master Fund Ltd. | — | Purchase | 491,097 | $0.99 | $486,186 | 45,628,997 | Jan 11, 2022 |
| Wilkins H Jeffrey | Chief Medical Officer | Purchase | 6,371 | $1.57 | $10,002 | 33,373 | Dec 10, 2021 |
| Sullivan Christopher Ryan | Chief Accounting Officer | Purchase | 955 | $1.57 | $1,499 | 9,004 | Dec 10, 2021 |
| Harrell James Archie Jr | Chief Commercial Officer | Purchase | 1,093 | $1.57 | $1,716 | 36,766 | Dec 10, 2021 |
| NEIL GARRY ARTHUR | Chief Scientific Officer | Purchase | 4,267 | $1.57 | $6,699 | 85,639 | Dec 10, 2021 |
| Greenway Schond L. | CFO | Purchase | 2,231 | $1.57 | $3,503 | 3,883 | Dec 10, 2021 |
| ARMISTICE CAPITAL, LLC | — | Purchase | 5,454,545 | $2.20 | $11,999,999 | 45,000,000 | Sep 15, 2021 |
| Boyd Steven | — | Purchase | 20,000 | $2.78 | $55,600 | 39,300,000 | Aug 16, 2021 |
| ARMISTICE CAPITAL, LLC | — | Purchase | 100,000 | $2.69 | $269,000 | 39,200,000 | Aug 6, 2021 |
| NEIL GARRY ARTHUR | Chief Scientific Officer | Purchase | 3,692 | $2.28 | $8,418 | 81,372 | Jun 10, 2021 |
| Greenway Schond L. | CFO | Purchase | 652 | $2.68 | $1,747 | 1,652 | Jun 10, 2021 |